نتایج جستجو برای: پروبیوتیک abt 10

تعداد نتایج: 1019339  

2015
David Chiron Christelle Dousset Carole Brosseau Cyrille Touzeau Sophie Maïga Philippe Moreau Catherine Pellat-Deceunynck Steven Le Gouill Martine Amiot

The aggressive biological behavior of mantle cell lymphoma (MCL) and its short response to current treatment highlight a great need for better rational therapy. Herein, we investigate the ability of ABT-199, the Bcl-2-selective BH3 mimetic, to kill MCL cells. Among MCL cell lines tested (n = 8), only three were sensitive (LD50 < 200 nM). In contrast, all primary MCL samples tested (n = 11) were...

Journal: :The Journal of pharmacology and experimental therapeutics 2012
Daniel R Premkumar Esther P Jane Joseph D DiDomenico Natalie A Vukmer Naomi R Agostino Ian F Pollack

We observed that glioma cells are differentially sensitive to N-{4-[4-(4'-chloro-biphenyl-2-ylmethyl)-piperazin-1-yl]-benzoyl}-4-(3-dimethylamino-1-phenylsulfanylmethyl-propylamino)-3-nitro-benzenesulfonamide (ABT-737) and administration of ABT-737 at clinically achievable doses failed to induce apoptosis. Although elevated Bcl-2 levels directly correlated with sensitivity to ABT-737, overexpre...

Journal: :Antimicrobial agents and chemotherapy 2001
K L Credito G Lin G A Pankuch S Bajaksouzian M R Jacobs P C Appelbaum

The activity of the ketolide ABT-773 against Haemophilus and Moraxella was compared to those of 11 other agents. Against 210 Haemophilus influenzae strains (39.0% beta-lactamase positive), microbroth dilution tests showed that azithromycin and ABT-773 had the lowest MICs (0.5 to 4.0 and 1.0 to 8.0 microg/ml, respectively), followed by clarithromycin and roxithromycin (4.0 to >32.0 microg/ml). O...

Journal: :The Journal of pharmacology and experimental therapeutics 1998
D H Albert P E Malo P Tapang T K Shaughnessy D W Morgan C D Wegner M L Curtin G S Sheppard L Xu S K Davidsen J B Summers G W Carter

Platelet-activating factor (PAF) may be an important mediator of allergic rhinitis. In the present study we evaluated the effectiveness of a recently described PAF antagonist (ABT-491) in rat and guinea pig models of allergic rhinitis. PAF, when perfused through the nasal passages of anesthetized Brown Norway rats, provoked an acute increase, measured as dye leakage, in nasal vascular permeabil...

Journal: :Antimicrobial agents and chemotherapy 2000
E J Goldstein D M Citron C V Merriam Y Warren K Tyrrell

We studied the comparative in vitro activities of ABT-773, a new ketolide, against 268 aerobic and 148 anaerobic recent isolates from clinical bites using an agar dilution method and inocula of 10(4) CFU/spot for aerobes and 10(5) CFU for anaerobes. The following are the MIC ranges and MICs at which 90% of isolates are inhibited (MIC(90)s) of ABT-773 for various isolates, respectively: Pasteure...

Journal: :The Journal of pharmacology and experimental therapeutics 1998
A W Bannon M W Decker P Curzon M J Buckley D J Kim R J Radek J K Lynch J T Wasicak N H Lin W H Arnold M W Holladay M Williams S P Arneric

The antinociceptive effects of ABT-594, a novel nicotinic acetylcholine receptor (nAChR) ligand, were examined in rats in models of acute thermal (hot box) and persistent chemical (formalin test) pain. Also, the effects of ABT-594 treatment on motor function and electroencephalogram (EEG) were determined. In the hot box and formalin test (i.e., phase 1 and 2), acute treatment with ABT-594 (0.03...

Journal: :Cancer research 2011
Shivaani Kummar Alice Chen Jiuping Ji Yiping Zhang Joel M Reid Matthew Ames Lee Jia Marcie Weil Giovanna Speranza Anthony J Murgo Robert Kinders Lihua Wang Ralph E Parchment John Carter Howard Stotler Larry Rubinstein Melinda Hollingshead Giovanni Melillo Yves Pommier William Bonner Joseph E Tomaszewski James H Doroshow

A phase I trial of ABT-888 (veliparib), a PARP inhibitor, in combination with topotecan, a topoisomerase I-targeted agent, was carried out to determine maximum tolerated dose (MTD), safety, pharmacokinetics, and pharmacodynamics of the combination in patients with refractory solid tumors and lymphomas. Varying schedules and doses of intravenous topotecan in combination with ABT-888 (10 mg) admi...

Journal: :The Journal of pharmacology and experimental therapeutics 2000
E A Kowaluk J Mikusa C T Wismer C Z Zhu E Schweitzer J J Lynch C H Lee M Jiang S S Bhagwat A Gomtsyan J McKie B F Cox J Polakowski G Reinhart M Williams M F Jarvis

Adenosine kinase (AK; EC 2.7.1.20) is a key intracellular enzyme regulating intra-and extracellular concentrations of adenosine (ADO), an endogenous neuromodulator, antinociceptive, and anti-inflammatory autocoid. AK inhibition provides a means of potentiating local tissue concentrations of endogenous ADO, and AK inhibitors may have therapeutic potential as analgesic and anti-inflammatory agent...

Journal: :Nuclear medicine communications 2011
Niklaus G Schaefer Engles James Richard L Wahl

PURPOSE To assess the possible radiosensitizing capabilities of two different poly(ADP-ribose) polymerase (PARP) inhibitors in combination with external beam and I-tositumomab in a non-Hodgkin's lymphoma cell line. METHODS AND MATERIALS Epstein-Barr virus-infected human Raji lymphoma cells with lentivirally transfected green fluorescent protein and luciferase in log-phase growth were incubate...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2010
J Michels S L Ellard L Le C Kollmannsberger N Murray E S Tomlinson Guns R Carr K N Chi

BACKGROUND This study investigated the safety, pharmacokinetics (PK) and clinical antitumor activity of ABT-751, a novel sulfonamide antimitotic and vascular disrupting agent, in combination with docetaxel (Taxotere) in patients with castration-resistant prostate cancer (CRPC). PATIENTS AND METHODS Patients received docetaxel (60-75 mg/m(2)) i.v. on day 1 and ABT-751 (100-200 mg) orally daily...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید